U.K. Seeks Life Sciences Boost With UCB, Roche Investments
Europe’s Drug Regulator Is Backing Away From the U.K.
The Quest for a Weight-Loss Drug That Actually Works
Genetic Database in U.K. Expects Up to $320 Million in Funds
GlaxoSmithKline Plc is considering whether to develop a new vaccine against Gonorrhea.
Theresa May's Insulin Supplies Look Safe in a No-Deal Brexit
Age-Old, Sexually Transmitted Disease Making a Comeback
Vaccines Give Sanofi, Glaxo a Shot of Optimism as Views Raised
First Brazilians started gobbling up junk food. Now they’re clamoring for weight-loss drugs.
Sanofi Earnings Grow Again as Drugmaker's Forecast Edges Higher
The company is also looking to expand in areas including cell, gene therapies to build on its purchase of drugmaker AveXis Inc.
Failure to work out a deal could lead to exodus of highly skilled specialists, crippling research, Francis Crick Institute said.
Novartis Targets Prostate Cancer With Deal to Buy Endocyte
Novartis to Buy Cancer Drugmaker Endocyte for $2.1 Billion
The Swiss Drugmaker Taking on Silicon Valley Giants
Diabetes Drug's Results Push Lilly to Look at Obesity Too
Glaxo Resumes Payments to Doctors That Were Halted After U.S. Probe
Tencent Pact With Novartis Shows Big Pharma's Ambitions in China
Novartis Cancer Therapy Kymriah Hits First Hurdle in Europe
Drug Industry to Invest More Despite Brexit, U.K. Adviser Says
Sanofi and Bayer Are Swapping Executives